Abstract: The Mini-mental State Examination (MMSE) is a brief cognitive screening instrument frequently used to track Alzheimer disease (AD) progression. We investigated the structural neuroimaging correlates of MMSE performance in patients with clinical and preclinical AD. We analyzed structural magnetic resonance imaging data from 29 probable AD and 5 MCI patients who later converted to probable AD using an advanced 3D cortical mapping technique. MMSE scores were entered as covariates in a general linear model that predicted the gray matter density at each cortical surface point. The results were corrected for multiple comparisons by permutation testing. The global permutation-corrected significance for the maps linking gray matter loss and cognitive decline was P = 0.005 for the left and P = 0.012 for the right hemisphere. Strongest correlations between MMSE score and gray matter integrity were seen in the entorhinal, parahippocampal, precuneus, superior parietal, and subgenual cingulate/orbitofrontal cortices. Significant correlations were also seen bilaterally in the temporal, the middle frontal and the left angular and supramarginal gyri. As a global cognitive measure, MMSE depends on the integrity of widely distributed cortical areas in both brain hemispheres with left-sided predominance.
T he Mini-mental State Examination (MMSE) is a brief cognitive screening test also used for tracking cognitive decline in patients with dementia. 1 This short battery tests orientation, language, short-term memory, construction, and attention. It is the most widely used cognitive instrument for evaluating patients with Alzheimer disease (AD). AD progression manifests clinically with cognitive decline, structurally with brain atrophy and pathologically with progressive accumulation of neuritic plaques and neurofibrillary tangles. Advances in neuroimaging have revolutionized clinical neuropsychology by permitting brain-behavior correlations that provide insight into normal and abnormal cognition. Clinical trials in AD use various cognitive instruments including the MMSE. However, the association between MMSE and gray matter atrophy has rarely been investigated with techniques exploring the whole cortex. In this study we use an advanced 3D cortical analysis technique to study and visualize the associations between total MMSE score and cortical atrophy in clinical and preclinical AD. Our technique surveys the entire cerebral cortex while controlling for sulcal and gyral variability. It has been successfully employed in several neurodegenerative, [2] [3] [4] psychiatric, 5 and developmental studies.
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METHODS
Patients
Our study included 29 probable AD and 5 amnestic MCI subjects who later converted to probable AD. All subjects were participants in the UCLA Alzheimer's Disease Research Center database and were recruited and consented following the restrictions and policies of the UCLA Institutional Review Board. The diagnostic workup consisted of a physician interview, general and neurologic examination, MMSE, tests of general intellectual functioning [ 20 All 5 MCI patients met NINCDS-ADRDA criteria for probable AD on a subsequent annual follow-up visit. Additional inclusion criteria were age 55 to 90 years, no evidence of concurrent general medical condition of sufficient severity to impact cognition, no history of drug or alcohol abuse, no concurrent psychiatric or other neurologic illness. We excluded subjects whose baseline images were acquired more than 6 months from the date of neuropsychologic evaluation and those with conditions precluding safe performance of magnetic resonance imaging (MRI).
Imaging Data Acquisition and Analysis
MRI scans were acquired on a 1.5 T Signa MRI scanner (Milwaukee, Wisconsin) according to the following protocol: 3D SPGR (spoiled gradient echo), gapless coronal acquisition perpendicular to the long axis of the hippocampus, TR 28 ms, TE 6 ms, FOV 220 mm, 256 Â 192 matrix, slice thickness 1.5 mm. We used a 9-parameter linear transformation for spatial normalization and scaling of each patient's image to the ICBM53 average brain imaging template. 21 To ascertain whether brain scaling has influenced our results by differentially scaling the gray matter and potentially negating the atrophy effects between our AD and MCI subjects we compared the native-space-to-ICBM transformation estimates for our AD and MCI patients (2 sample t test, t = À 0.53; P = 0.6) and looked for a correlation between the subjects' transfomation estimates and their MMSE score (bivariate r = 0.0193; partial r = 0.07 corrected for age, sex, education, and race). Image intensity nonuniformity correction was applied to each image using a regularized tricubic B-spline approach. 22 The scalp and other extracerebral tissues were automatically removed. All volumes were visually inspected and mislabeled brain and nonbrain tissues manually corrected. After 3D hemispheric reconstruction, 38 sulci per hemisphere were traced according to a protocol with established interrater and intrarater reliability. 23, 24 A group average sulcal map was computed. The parameterized, flattened hemispheric surfaces were warped to the average sulcal representations assuring explicit matching of corresponding gyri, as far as possible, before averaging of data on gray matter distribution across subjects. 3D maps of gray matter distribution were extracted 22 and mapped onto the corresponding parametric hemispheric model in exact spatial correspondence. As in many prior studies by our group and others, a commonly used measure of regional gray matter volume, known as gray matter density, was defined as the proportion of tissue segmenting as gray matter in a small spherical region (10 mm radius) around each point on each subject's cortical surface model (Wright et al, 25 Good et al, 26 Cannon et al, 27 Mechelli et al, 28 Thompson et al, 29 who have used similar measures). An average group 3D gray matter density map was created for all subjects in the study. Data on individual variations in gray matter density was computed and regressed against MMSE scores. MMSE scores were entered as covariates in a general linear model that predicted the 3D cortical map of gray matter density for each subject. This procedure yields a map of correlation coefficients (r-values) across the whole cortex, with each r-value representing the correlation between gray matter at that point and each subject's MMSE score. The results were corrected for multiple comparisons by permutation testing using a threshold of P<0.01.
3 A detailed explanation of the permutation test is provided elsewhere. 30 We additionally explored for possible confounding of the association between MMSE and gray matter density by age. We first explored this association by developing 3D correlations and statistical maps, which were corrected for multiple comparisons by permutation testing using a threshold of P<0.01 (Fig. 2) . We then developed a linear regression model with MMSE as the dependent and age as the predictor variable and a linear regression model with MMSE as the dependent and age and the mean regional gray matter density in the entorhinal, precuneus, and lateral parietal regions as independent predictors.
RESULTS
Demographic data on the subjects are provided in Table 1 . The amnestic MCI subgroup had an average age of 70.8 years (SD 7.9), 16.5 years of education (SD 3.4 y), and a MMSE score of 28.8 (SD 0.96). The average neuropsychologic test scores for the amnestic MCI subgroup are provided in Table 2 .
The global permutation-corrected significance for the maps associating MMSE performance with cortical atrophy was P = 0.005 for the left and P = 0.012 for the right hemisphere. The 3D statistical maps showed strong left-sided lateralization, with greater effect sizes and more extensive cortical areas linked to MMSE score in the left hemisphere (Fig. 1) . MMSE score correlated strongly with gray matter integrity in the entorhinal and parahippocampal cortices [Brodmann area (BA) 28], precuneus (BA 7), superior parietal lobule (BA 7), and subgenual cingulate/orbitofrontal areas (BA 32 and 12). Strong correlations were also seen with the midposterior portions of the superior (BA 22), middle (BA 21), and inferior temporal (BA 20) gyri on the left and the (Fig. 1) . Figure 2 shows the association between age and gray matter density. Significant age effects were seen bilaterally in the medial and lateral frontal and occipital association cortices, the lower portions of the sensorimotor strip, the superior temporal gyrus, as well as parts of the medial temporal, entorhinal, anterior and posterior cingulate, and superior parietal cortices on the left. The global permutation-corrected significance for the maps associating age with cortical atrophy was P = 0.005 for the left and P = 0.04 for the right hemisphere. The correlation between age and MMSE (r = À 0.16, P = 0.37) and a linear regression model of MMSE by age (R 2 = 0.04, F = 1.185, P = 0.29) were not significant. The linear regression model with MMSE as the dependent and age and the regional gray matter density of the entorhinal, precuneus, and lateral parietal regions as independent predictors yielded R 2 = 0.47, F = 3.149, P = 0.016. The correlation values between the regional gray matter density of the entorhinal, precuneus, and superior parietal regions and the MMSE score ranged between r = 0.44 and 0.6 (Table 3 ). Figure 3 shows the corresponding regression plots. The location, ICBM co-ordinates, and statistical significance of the regions showing the strongest associations of MMSE and gray matter atrophy can be found in Table 4 .
DISCUSSION
As a global cognitive measure MMSE is thought to reflect the integrity of widely distributed cognitive networks situated in both hemispheres with left sided predominance. Using innovative 3D mapping techniques FIGURE 2. Statistical (top) and correlation maps (bottom) demonstrating the association between the age and gray matter density in subjects with clinical and preclinical AD. 14 age-matched normal controls. We explored the correlation between MMSE score and cortical density and found significant associations between gray matter atrophy and low MMSE scores in mesial and lateral temporal, parietal, and frontal association cortices. The associations showed a temporal gradient and were substantially stronger in follow-up in many of the above regions. 3 In the present study, we focused on clinical and preclinical AD in search for disease-specific associations. Longitudinal AD cognitive correlation maps may be of interest as they may show that the strength of the associations and perhaps even the regional correlation pattern is stage specific as a function of AD stagedependent variability in the test measure (eg, MMSE) and gray matter integrity.
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Using voxel-based morphometry in patients with AD, Frisoni et al 31 reported correlations between total MMSE score and somewhat surprisingly right more than left temporal, bilateral posterior cingulate/precuneus, and right superior parietal gray matter atrophy. Several other groups have investigated the association between global cognitive measures and regional brain volumes. The hippocampus, one of the first regions to be affected by AD, was reported to show almost as strong correlation with MMSE (r = 0.47) as we found for the gray matter regions in our study (Table 3) . 32 In another longitudinal study, the correlation between MMSE decline and atrophy of the hippocampi and whole brain were, respectively, r = 0.22, P>0.05 and r = 0.38, P<0.05 in MCI and r = 0.35, P<0.05 and r = 0.47, P<0.05 in AD. 33 Using the magnetization transfer ratio (MTR) technique van der Flier et al 34 reported the following correlations of the relative peak MTR height with MMSE: whole brain r = 0.58, frontal lobe r = 0.52, and temporal lobe r = 0.58. Mean MTR, however, did not correlate with MMSE in any region. The strength of these correlations is comparable to ours. 34 Another group reported total cerebral volume to correlate strongly with another more accurate measure for AD severity-the sum of boxes Clinical Dementia Rating scale score (r = À 0.39, P = 0.006). 35 Our linear regression model with MMSE as the dependent and age and regional gray matter density of the entorhinal, precuneus, and lateral parietal regions as independent predictors was statistically significant (R 2 = 0.47, F = 3.149, P = 0.016). Our results are similar to those reported by Mouton et al 36 in a postmortem study of severe AD patients with mean MMSE 6.7 (SD 6.6) and normal elderly subjects. Their linear regression model with MMSE as the dependent and cortical volume and age as predictors yielded R 2 = 0.58, F = 27.9, P = 0.0001). 36 In their study, however, the gray matter volumes were estimated postmortem directly from sectioned brains and were devoid of imaging artifacts introduced by the MRI scanner, the skull, scalp, and other soft tissues. These factors probably contribute significantly to their better statistical significance.
Three positron emission tomography (PET) studies and one single photon emission computed tomography (SPECT) study investigated the correlation between MMSE and cortical metabolism. The 2 PET studies in AD showed correlations with frontal, temporal, and parietal metabolism. 37, 38 The AD SPECT study reported an association between MMSE and left temporal perfusion. 39 In a cohort of MCI and normal elderly total MMSE score correlated with bilateral inferior frontal, medial and inferior temporal, anterior cingulate, as well as left superior temporal, precentral, parietal, and insular PET hypometabolism. 40 Our findings are consistent with those reported in the PET and SPECT literature and seem to conform to the pathologic distribution of AD pathology with involvement of the association and relative preservation of the primary cortices.
The strengths and limitations of our study need be recognized. We used a cross-sectional design that assured adequate heterogeneity, and sufficient breadth of disease burden, in our AD sample. However, a longitudinal design-if large enough to encompass symptomatic variability-may offer greater power to link disease progression with MMSE decline and allow for exploration of stagespecific phenomena. In the MCI subgroup, etiologic heterogeneity is unwelcome if we want to focus on understanding brain changes in the AD spectrum. We thus limited our selection to those MCI patients who subsequently met the stringent diagnostic criteria for probable AD. The diagnosis of definite AD requires pathologic examination, which is not available for our subjects. Finally, the entorhinal region is one of the most challenging areas for imaging analysis as it is highly variable in shape and highly susceptible to magnetic susceptibility artifacts. With the present technique we have minimized possible errors by first using intensity normalization and then applying cortical pattern matching to control for entorhinal variability. The technique can be considered an extension of the VBM methodology where instead of smoothing we explicitly coregister cortical surface data using sulcal constraints. For the entorhinal and parahippocampal cortex we used the collateral sulcus laterally and the invagination toward the hippocampus medially. AD is a relentlessly progressive neurodegenerative disorder with very high prevalence among the elderly. Its current economical impact is enormous and on a continuous rise. 41 AD researchers and the pharmaceutical industry are actively searching for efficient diseasemodifying AD therapies. These compounds would ideally demonstrate both cognitive and structural evidence for slowing disease progression. Investigating the structural correlates of cognitive decline will not only provide important evidence about various cognitive networks; it will also provide an excellent foundation for the utility of neuroimaging as a surrogate biomarker in clinical trials. In that context, we would hope to not only demonstrate drug-induced slowing in cortical atrophy but also a strong correlation between these regional effects and clinical stability or improvement.
